Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer

Programmed death ligand 1 (PD-L1) is overexpressed in the most aggressive breast cancer subtype, triple-negative breast cancer (TNBC), assisting the eradication of antitumor immunity, and thereby enhancing the survival of the tumor. This study explored how hesperidin affects PD-L1 expression, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongtawelert, Prachya, Wudtiwai, Benjawan, Shwe, Thuzar Hla, Pothacharoen, Peraphan, Phitak, Thanyaluck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024188/
https://www.ncbi.nlm.nih.gov/pubmed/31936263
http://dx.doi.org/10.3390/molecules25020252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024188/
https://www.ncbi.nlm.nih.gov/pubmed/31936263
http://dx.doi.org/10.3390/molecules25020252

Ejemplares similares